{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
Immunoreaction cartridges to be used with the automated LUMIPULSE G System for the quantitative measurement of β-amyloid1-40 in human plasma. This product is not for use in diagnostic procedures, for ‘Research Use Only.
Fujirebio
... concordant with amyloid PET, and is able to differentiate between Alzheimer's disease and non-Alzheimer's disease neurodegenerative diseases and to predict progression to Alzheimer's ...
Fujirebio
Immunoreaction cartridges to be used with the automated LUMIPULSE G System for the quantitative measurement of β-amyloid1-42 in human plasma. This product is not for use in diagnostic procedures, for ‘Research Use Only’.
Fujirebio
... Immunoreaction cartridges to be used with the automated LUMIPULSE G System for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human K2EDTA plasma. This product is not for use in diagnostic procedures, for ‘Research ...
Fujirebio
... an adjunct to other diagnostic evaluations.
Kit components / formats
- Lumipulse® G pTau 217 Plasma Immunoreaction Cartridges — Product number: 81544 — Packaging: 3 x 14 Tests
- Lumipulse®
Fujirebio
Sample volume: 0.025 ml
... CSF-Tau and CSF-β-amyloid(1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression (1-6). Details Features & Benefits ...
Fujirebio
Sample volume: 0.075 ml
... CSF-Tau and CSF-β-amyloid(1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression. The discrimination of AD from non-AD ...
Fujirebio
Sample volume: 0.025 ml
... CSF-Tau and CSF-β-amyloid(1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression (1-6). Details Features & Benefits User-friendly ...
Fujirebio
Sample volume: 0.3 ml
... CSF-Tau and CSF-β-amyloid(1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression.1-5 The discrimination of AD from non-AD ...
Fujirebio
Sample volume: 0.075 ml
... CSF-Tau and CSF-β-amyloid(1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression.1-5 The discrimination of AD from non-AD ...
Fujirebio